Home LiteratureArticle Details
PMID: 9184208 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes.

The EMBO journal ·Vol. 16 ·No. 10 ·1997-05-15 ·Pages 2610-20

Nykjaer A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F

Abstract

The GPI-anchored urokinase plasminogen activator receptor (uPAR) does not internalize free urokinase (uPA) but readily internalizes and degrades uPA:serpin complexes in a process that requires the alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha2MR-LRP). This process is accompanied by the internalization of uPAR which renders it resistant to phosphatidylinositol-specific phospholipase C (PI-PLC). In this paper we show that during internalization of uPA:serpins at 37 degrees C, analysed by FACScan, immunofluorescence and immunoelectron microscopy, an initial decrease of cell surface uPAR was observed, followed by its reappearance at later times. This effect was not due to redistribution of previously intracellular receptors, nor to the surface expression of newly synthesized uPAR. Recycling was directly demonstrated in cell surface-biotinylated, uPA:PAI-1-exposed cells in which biotinylated uPAR was first internalized and subsequently recycled back to the surface upon incubation at 37 degrees C. In fact, uPAR was resistant to PI-PLC after the 4 degrees C binding of uPA:PAI-1 to biotinylated cells, but upon incubation at 37 degrees C PI-PLC-sensitive biotinylated uPAR reappeared at the cell surface. Binding of uPA:PAI-1 by uPAR, while essential to initiate the whole process, was, however, dispensable at later stages as both internalization and recycling of uPAR could be observed also after dissociation of the bound ligand from the cell surface.

MeSH Terms
Animals Biological Transport Cell Membrane/metabolism Endocytosis Fluorescent Antibody Technique Humans Ligands Mice Microscopy, Fluorescence Monocytes/metabolism Phosphatidylinositol Diacylglycerol-Lyase Phosphoinositide Phospholipase C Plasminogen Activator Inhibitor 1/metabolism Protein Binding Receptors, Cell Surface/isolation & purification,metabolism Receptors, Urokinase Plasminogen Activator Serpins/metabolism Type C Phospholipases/metabolism Urokinase-Type Plasminogen Activator/metabolism
Chemicals
Ligands PLAUR protein, human Plasminogen Activator Inhibitor 1 Plaur protein, mouse Receptors, Cell Surface Receptors, Urokinase Plasminogen Activator Serpins Type C Phospholipases Phosphoinositide Phospholipase C Urokinase-Type Plasminogen Activator Phosphatidylinositol Diacylglycerol-Lyase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Nykjaer A
Department of Medical Biochemistry and Cell Biology, University of Aarhus, Aarhus-C, Denmark.
Conese M
Christensen E I
Olson D
Cremona O
Gliemann J
Blasi F
References (40)
40 references, click to expand
  1. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation.
    Cell. 1992 Oct 30;71(3):411-21 PMID: 1423604
  2. Prevention of metastasis by inhibition of the urokinase receptor.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5021-5 PMID: 8389464
  3. Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7422-6 PMID: 1502153
  4. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
    EMBO J. 1990 Apr;9(4):1079-85 PMID: 2157592
  5. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    J Biol Chem. 1992 May 5;267(13):9129-33 PMID: 1315748
  6. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    J Cell Biol. 1989 May;108(5):1987-95 PMID: 2523891
  7. Highly structured sequence homology between an insertion element and the gene in which it resides.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):493-7 PMID: 16593538
  8. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
    J Cell Biol. 1996 Sep;134(6):1563-71 PMID: 8830783
  9. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    J Biol Chem. 1991 Nov 5;266(31):21232-8 PMID: 1718973
  10. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
    J Biol Chem. 1986 Dec 5;261(34):15819-22 PMID: 3023326
  11. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
    J Biol Chem. 1995 Nov 3;270(44):26550-7 PMID: 7592875
  12. A study of positive staining of ultrathin frozen sections.
    J Ultrastruct Res. 1978 Jun;63(3):287-307 PMID: 79660
  13. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
    EMBO J. 1996 Apr 1;15(7):1572-82 PMID: 8612581
  14. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
    Trends Pharmacol Sci. 1994 Jan;15(1):25-9 PMID: 8140655
  15. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.
    FEBS Lett. 1991 Aug 19;288(1-2):233-6 PMID: 1715292
  16. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
    J Exp Med. 1995 Apr 1;181(4):1381-90 PMID: 7535337
  17. Purification of urokinase by affinity chromatography.
    Biochim Biophys Acta. 1976 Aug 12;445(1):215-22 PMID: 953032
  18. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo.
    Cell. 1988 Feb 12;52(3):321-8 PMID: 3125981
  19. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.
    J Cell Biol. 1988 Dec;107(6 Pt 1):2437-45 PMID: 2848851
  20. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.
    J Biol Chem. 1991 Jul 5;266(19):12752-8 PMID: 1829461
  21. Identification of the urokinase receptor as an adhesion receptor for vitronectin.
    J Biol Chem. 1994 Dec 23;269(51):32380-8 PMID: 7528215
  22. Urokinase receptor. An activation antigen in human T lymphocytes.
    J Immunol. 1994 Jan 15;152(2):505-16 PMID: 8283034
  23. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    J Cell Biol. 1995 Dec;131(6 Pt 1):1609-22 PMID: 8522616
  24. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.
    Cell Regul. 1990 Dec;1(13):1043-56 PMID: 1966892
  25. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.
    Nature. 1996 Oct 3;383(6599):441-3 PMID: 8837777
  26. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
    Cancer Res. 1988 Mar 1;48(5):1270-8 PMID: 2963689
  27. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
    J Cell Biol. 1991 Nov;115(4):1107-12 PMID: 1659573
  28. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
    EMBO J. 1990 Feb;9(2):467-74 PMID: 1689240
  29. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    J Cell Biol. 1990 Aug;111(2):783-92 PMID: 2166055
  30. Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor.
    J Biol Chem. 1994 Jul 8;269(27):17886-92 PMID: 8027043
  31. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.
    Clin Cancer Res. 1995 Oct;1(10):1079-87 PMID: 9815897
  32. On the preparation of cryosections for immunocytochemistry.
    J Ultrastruct Res. 1984 Oct;89(1):65-78 PMID: 6544882
  33. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    Cancer Res. 1996 May 15;56(10):2428-33 PMID: 8625323
  34. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
    J Biol Chem. 1991 Jan 25;266(3):1926-33 PMID: 1846368
  35. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
    J Cell Biol. 1994 Jul;126(1):259-70 PMID: 7517943
  36. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors.
    J Biol Chem. 1991 Jul 25;266(21):14011-7 PMID: 1713212
  37. Regulation of integrin function by the urokinase receptor.
    Science. 1996 Sep 13;273(5281):1551-5 PMID: 8703217
  38. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
    J Cell Biol. 1989 Feb;108(2):693-702 PMID: 2537321
  39. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).
    Annu Rev Biochem. 1994;63:601-37 PMID: 7979249
  40. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.
    J Clin Invest. 1996 Sep 1;98(5):1133-41 PMID: 8787676
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1997-05-15
Pages
2610-20
Language
English
Region
England
NLM ID
8208664
PMCID
PMC1169872
Subset
IM
Grants
Telethon · 168 · Italy
Telethon · TGT06S01 · Italy
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com